Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50,873,000 | $71,536,000 | $96,233,000 | $95,024,000 |
| Short-Term Investments | $14,872,000 | $8,300,000 | $8,300,000 | $14,022,000 |
| Receivables | $49,442,000 | $52,984,000 | $47,853,000 | $55,147,000 |
| Inventory | $24,163,000 | $22,081,000 | $17,678,000 | $15,107,000 |
| Other Curr. Assets | $5,118,000 | $3,430,000 | $2,828,000 | $2,589,000 |
| Total Curr. Assets | $144,468,000 | $158,331,000 | $172,892,000 | $181,889,000 |
| Property Plant & Equip (Net) | $67,448,000 | $47,665,000 | $34,778,000 | $22,524,000 |
| Goodwill | $9,260,000 | $9,655,000 | $7,147,000 | $7,189,000 |
| Intangibles | $11,414,000 | $11,959,000 | $6,160,000 | $5,469,000 |
| Long-Term Investments | $9,745,000 | $23,824,000 | $20,209,000 | $15,444,000 |
| Tax Assets | $3,087,000 | $2,647,000 | $1,750,000 | $1,489,000 |
| Other NC Assets | $19,943,000 | $13,389,000 | $12,888,000 | $18,547,000 |
| Total NC Assets | $120,897,000 | $109,139,000 | $82,932,000 | $70,662,000 |
| Other Assets | $3,000 | $3,000 | $3,000 | $3,000 |
| Total Assets | $265,368,000 | $267,473,000 | $255,827,000 | $252,554,000 |
| Liabilities | – | – | – | – |
| Payables | $8,264,000 | $17,305,000 | $18,056,000 | $17,444,000 |
| Short-Term Debt | $343,000 | $379,000 | $261,000 | $170,000 |
| Tax Payable | $2,259,000 | $4,847,000 | $4,908,000 | $4,475,000 |
| Deferred Revenue | $0 | $32,589,000 | $27,870,000 | $28,148,000 |
| Other Curr. Liab. | $35,557,000 | $991,000 | $714,000 | $466,000 |
| Total Curr. Liab. | $46,423,000 | $56,111,000 | $51,809,000 | $50,703,000 |
| LT Debt | $503,000 | $608,000 | $531,000 | $460,000 |
| Deferred Rev, NC | $0 | $939,000 | $2,034,000 | $2,019,000 |
| Deferred Tax Liab, NC | $1,554,000 | $0 | $1,310,000 | $1,564,000 |
| Other NC Liab. | $3,418,000 | $4,999,000 | $3,554,000 | $3,773,000 |
| Total NC Liab. | $5,475,000 | $6,546,000 | $6,119,000 | $6,252,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $846,000 | $987,000 | $792,000 | $629,000 |
| Total Liabilities | $51,898,000 | $62,657,000 | $57,928,000 | $56,955,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3,450,000 | $3,450,000 | $3,450,000 | $3,450,000 |
| Retained Earnings | $208,240,000 | $205,681,000 | $194,285,000 | $200,534,000 |
| AOCI | $26,021,000 | $19,929,000 | $14,124,000 | $11,138,000 |
| Other Equity | -$24,245,000 | -$24,244,000 | -$13,960,000 | -$19,523,000 |
| Total Equity | $213,466,000 | $204,816,000 | $197,899,000 | $195,599,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4,000 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $265,368,000 | $267,473,000 | $255,827,000 | $252,554,000 |
| Net Debt | -$50,027,000 | -$70,549,000 | -$95,441,000 | -$94,394,000 |